proton therapy in the pediatric population

46
Proton Therapy in the Pediatric Population Jeffrey Buchsbaum, MD, PhD, AM Associate Professor, IU School of Medicine Departments of Radiation Oncology, Pediatrics, and Neurological Surgery Radiation Oncologist, IU Health Proton Therapy Center AAMD Meeting in Indianapolis April 13, 2013

Upload: reza-khalili

Post on 23-Nov-2015

10 views

Category:

Documents


1 download

DESCRIPTION

Proton Therapy in the Pediatric Population

TRANSCRIPT

  • Proton Therapy in the Pediatric Population

    Jeffrey Buchsbaum, MD, PhD, AMAssociate Professor, IU School of Medicine Departments of Radiation

    Oncology, Pediatrics, and Neurological SurgeryRadiation Oncologist, IU Health Proton Therapy Center

    AAMD Meeting in Indianapolis

    April 13, 2013

  • Disclosure Slide

    The speaker is salaried and is not being paid to speak and has no conflicts of interest.

    The speaker is a DABR and is licensed in Indiana, Ohio, Pennsylvania, Florida, and Tennessee.

    Standard CME disclosure forms have been filed with IU Health.

    2

  • The Conclusions

    Protons are better than traditional radiation for children for almost all types of cancer (likely also often better for adults) the dosimetry is different

    Protons are not available everywhere because of cost (to build the facilities ~ $150+ M)

    IU has perhaps the worlds finest proton beam, not all protons are the same

    Dosimetric issues are critical in the optimal treatment of children using proton therapy

    3

  • Thoughts on Pediatric Cancer

    4

    Title: "Connectivity of a Cognitive Computer Based on the Macaque Brain"Credit: Emmett McQuinn, Theodore M. Wong, Pallab Datta, Myron D. Flickner, RaghavendraSingh, Steven K. Esser, Rathinakumar Appuswamy, William P. Risk, and Dharmendra S.Modha; IBM Research - Almaden

  • Pediatric Radiation Oncologists

    Total COG Radoncs: 342

    Full Members: 68

    Those treating over 50 a year:

  • Numbers

    About 12,000 under 21 will be diagnosed this year with cancer in the United States

    3,000 will not win their fight

    About 5% of pediatric radiation cases will get proton therapy

    6

  • Trends: 2010 to 2011 Change

    7

    PPF

  • Proton Patterns of Care in the USA

    8

    PPF

  • The Three Largest Centers in 2011

    9

  • Pediatric Radiation History

  • The Classic Parts of Cancer Care

    Surgery

    Radiation

    Chemotherapy

    11

  • Where did radiation therapy come from?

    12

    1895 1920s 1950s to today

  • First MV Linear Accelerator: RB

    13

    This is Gordon Isaacs, the first patient treated with the linear accelerator (radiation therapy) for retinoblastoma in 1957.

    Gordon's right eye was removed January 11, 1957, because the cancer had spread. His left eye, however, had only a localized tumor that prompted Henry Kaplan to try to treat it with the electron beam.

    Gordon is now living in the East Bay, and his vision in the left eye is normal.

    (photo/text: NCI)

  • The Problem: Pediatric Cancer

    Rare

    Access (disparity/education)

    14

  • The Childrens Oncology Group: The National View on Proton Therapy

    All CNS protocols allow protons.

    National Q/C is required.

    Hypotheses are being tested

    15

  • Trends From 1973 to 2008

    16

    International Journal of Radiation Oncology * Biology * Physics 2013; 85:e151-e155

  • Trends From 1973 to 2008

    17

    International Journal of Radiation Oncology * Biology * Physics 2013; 85:e151-e155

  • Protons: Why? How?

  • Why? The Science in the Open

    19

    Figure by Mark Filipak. This was adapted from Figure 1 of "Proton beam therapy" by W P Levin, H Kooy, J S Loeffler, and T F DeLaney, British Journal of Cancer (2005) 93, 849854 downloaded by me from http://www.nature.com/bjc/journal/v93/n8/abs/6602754a.html

  • How: IU Health Proton Therapy Center

    20

  • What does this mean to a patient?

    21

  • Old Ideas in a New Format

    22

  • What is needed

    Standard goals of pediatric radiation therapy Immobilization Anatomic considerations Experience Protocols

    Team Good anesthesia (50% need it in this

    population)

    23

  • Anesthesia

    Our local team is exceptional.

    Our published data show our safety rate is the highest in the literature with our event rate being 0.07%.

    24

  • Medical and Surgical Support

    Riley is a COG site.

    IU Health Bloomington has a top level ED and can handle any acute issue either in-house or via life-flight.

    We see proton appropriate pediatric patients from all over the world.

    Local pediatricians help our families get past normal illnesses of childhood and assist us on any number of issues.

    25

  • IU CSI Board: Patent Pending

    26

  • Plugging

    27

  • Other Issues (in preparation for papers)

    Beam arrangement

    RBE concerns

    Toxicity differences from photons

    28

  • Some Nice Cases to View

    29

  • Case #1 Medulloblastoma (CSI) Disease can be in multiple locations in the

    spine and brain so we use craniospinal target

    Patients can be very young

    Overlap of dose can be lethal, so anesthesia is used

    Considered the most complex thing we do in radiation oncology

    30

  • Supine CSI with Protons at IUHPTC

    31

  • Secondary Cancer Risk

    Protons: 5-7% lifetime

    X-rays: 93% lifetime

    (MDACC model, published 2013)

    32

  • Case #2 Pelvic Osteosarcoma

    8yof with pelvic osteosarcoma after having had prior neuroblastoma in the same region when an infant about 5 years earlier.

    Spacer use via some Bloomington Hospital work that is unique (and recently published).

    Currently (3 years later) NED in the pelvis but with MDS from (presumably) all the chemotherapy. Doing well now after transplant for the MDS.

    33

  • Pelvic proton therapy with a spacer

    34

  • Case #3 - Retinoblastoma

    Bilateral, but limited to the eyes only

    Not chemoresponsive in this case

    Good vision in both eyes however

    History suggests that RB patients have extremely high late cancer ratesperhaps 30-40% rate for radiated tissue (normal is 10-15%)

    35

  • Bilateral Retinoblastoma

    36

  • Case #4 Desmoid of the Back17yof with a desmoid tumor s/p recurrence

    37

  • Case #5 Craniopharyngioma

    38

  • Case #6 Hodgkins

    39

  • Case #6 Hodgkins

    40

  • Case #6 Hodgkins

    41

  • Case #6 Hodgkins

    42

  • Case #6 Ewings Sarcoma (Askins)

    43

  • Case #7 Germinoma

    44

  • Case #7 Germinoma

    45

  • The End

    46